Wednesday, Compugen Ltd. (CGEN) announced the appointment of David Silberman as chief financial officer, starting August 15, 2024.
He will be succeeding Alberto Sessa, who will be leaving Compugen on the same day.
David has over 15 years of finance experience, with a decade specifically in healthcare and biotech industries. Before joining Compugen, he held the position of chief financial officer at Oramed Pharmaceuticals Inc.
In pre-market activity on the Nasdaq, the shares are trading at $2.09, up 2.96%.
For comments and feedback contact: editorial@rttnews.com
Business News
June 19, 2026 16:46 ET Major central banks continued to dominate the economic news flow this week too, led by the Federal Reserve, as they announced their latest policy decisions. The Federal Reserve policy session was in focus as it was the first to be led by the new chief Kevin Warsh. In Europe, central banks of the U.K. and Switzerland announced their rate decisions. In Asia, the Bank of Japan drew attention for its policy moves, while data out of China threw some light on the state of the economy.